Alzheimer's disease clinical trials with select modalities worldwide as of 2019

This statistic depicts the percentage of Alzheimer's disease clinical trials with select modalities as of 2019. According to the data, 53 percent of Alzheimer's disease clinical trials had small molecule sizes at that time. Modality is an important measure of how a drug can be delivered and administered. The term modality refers to the size of the molecules used in the drug.

Percentage of global Alzheimer's clinical trials with select modalities as of 2019

Exclusive Premium statistic

You need a Single Account for unlimited access.

  • Full access to 1m statistics

  • Incl. source references

  • Available to download in PNG, PDF, XLS format

Single Account

only $59 / month *
*Duration: 12 months, billed annually, single license

Access to this and all other statistics on 80,000 topics from

$708 / Year

Show detailed source information?
Register for free
Already a member?
Log in
Source

Release date

May 2019

Region

Worldwide

Survey time period

February 28, 2019

Statista Accounts: Access All Statistics. Starting from $708 / Year
Basic Account
Get to know the platform

You only have access to basic statistics.
This statistic is not included in your account!

Single Account
Your perfect start with Statista
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references

$59 / Month *

Corporate Account
Full access

Corporate solution including all features.

* All products require an annual contract.
   Prices do not include sales tax.

Statistics on "Clinical trials"

Statista Accounts: Access All Statistics. Starting from $708 / Year
Learn more about how Statista can support your business.